Prof Ranjan K Singh is thankful to DST- FIST programme, and ongoing BHU IOE scheme for financial support
Statements Author contributions EA: Writing original draft, Visualization, Writing review and editing, Methodology, Project administration, Conceptualization
It is most frequently considered for patients who have plateaued on semaglutide or tirzepatide, or where the additional metabolic dimension of glucagon receptor agonism is clinically justified
presented compelling evidence indicating the occurrence of a pancreatic-endocrine-bone axis governing fuel metabolism in humans [3]
Those numbers suggest that the transition is well-tolerated for the vast majority of patients
Evaluation of the safety of drugs and biological products used during lactation: workshop summary